FR2296428B1 - - Google Patents

Info

Publication number
FR2296428B1
FR2296428B1 FR7500174A FR7500174A FR2296428B1 FR 2296428 B1 FR2296428 B1 FR 2296428B1 FR 7500174 A FR7500174 A FR 7500174A FR 7500174 A FR7500174 A FR 7500174A FR 2296428 B1 FR2296428 B1 FR 2296428B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7500174A
Other languages
French (fr)
Other versions
FR2296428A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BAIGNES STE RADEGONDE LAITERIE
Original Assignee
BAIGNES STE RADEGONDE LAITERIE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BAIGNES STE RADEGONDE LAITERIE filed Critical BAIGNES STE RADEGONDE LAITERIE
Priority to FR7500174A priority Critical patent/FR2296428A1/fr
Publication of FR2296428A1 publication Critical patent/FR2296428A1/fr
Application granted granted Critical
Publication of FR2296428B1 publication Critical patent/FR2296428B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39516—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum from serum, plasma
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C11/00—Milk substitutes, e.g. coffee whitener compositions
    • A23C11/02—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins
    • A23C11/04—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins containing non-milk fats but no non-milk proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00—Working-up of proteins for foodstuffs
    • A23J3/04—Animal proteins
    • A23J3/08—Dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR7500174A 1975-01-03 1975-01-03 Composition de proteines a usage dietetique et therapeutique chez le nourrisson, l'enfant et l'adulte Granted FR2296428A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7500174A FR2296428A1 (fr) 1975-01-03 1975-01-03 Composition de proteines a usage dietetique et therapeutique chez le nourrisson, l'enfant et l'adulte

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7500174A FR2296428A1 (fr) 1975-01-03 1975-01-03 Composition de proteines a usage dietetique et therapeutique chez le nourrisson, l'enfant et l'adulte

Publications (2)

Publication Number Publication Date
FR2296428A1 FR2296428A1 (fr) 1976-07-30
FR2296428B1 true FR2296428B1 (enExample) 1978-12-29

Family

ID=9149403

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7500174A Granted FR2296428A1 (fr) 1975-01-03 1975-01-03 Composition de proteines a usage dietetique et therapeutique chez le nourrisson, l'enfant et l'adulte

Country Status (1)

Country Link
FR (1) FR2296428A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5344820A (en) * 1987-05-15 1994-09-06 Snow Brand Milk Products Co., Ltd. Infection protectant
US4977137B1 (en) * 1987-06-03 1994-06-28 Baylor College Medicine Lactoferrin as a dietary ingredient promoting the growth of the gastrointestinal tract
CA1333471C (en) * 1988-04-29 1994-12-13 Gustavo Bounous Whey protein concentrate as food supplement
US5230902A (en) * 1988-04-29 1993-07-27 Immunotec Research Corporation Undenatured whey protein concentrate to improve active systemic humoral immune response
CA1338682C (en) * 1988-12-23 1996-10-29 Gustavo Bounous Biologically active undenatured whey protein concentrate as food supplement
JP2805490B2 (ja) * 1989-02-07 1998-09-30 雪印乳業株式会社 細菌毒素中和剤
DE69214467T3 (de) * 1991-01-10 2000-09-28 Transcend Therapeutics, Inc. Verwendung von L-2-oxo Thiazolidin-4-carboxylat zur Behandlung von Atemnotsyndrom
US5430045A (en) * 1992-04-23 1995-07-04 Free Radical Sciences, Inc. Method of reducing or preventing bone marrow hypoplasia
WO2004060081A1 (en) * 2003-01-07 2004-07-22 N.V. Nutricia A method of improving nutrient utilisation by a mammal and a composition for use therein
CA3104747A1 (en) * 2018-06-27 2020-01-02 Arla Foods Amba Acidic beta-lactoglobulin beverage preparation
JP7610411B2 (ja) 2018-06-27 2025-01-08 アーラ フーズ エイエムビーエイ Ｂｌｇベースのインスタント飲料粉末

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1922811A1 (de) * 1969-05-05 1970-11-12 Sell Ernst Friedrich Verfahren zur Proteingewinnung aus Rohmolke
US3791283A (en) * 1970-08-28 1974-02-12 Gen Foods Corp Method for producing heat and acid stable whey protein material
GB1347443A (en) * 1972-07-24 1974-02-27 Akad Wissenschaften Ddr Simulated human milk

Also Published As

Publication number Publication date
FR2296428A1 (fr) 1976-07-30

Similar Documents

Publication Publication Date Title
FR2301939B1 (enExample)
FR2296428B1 (enExample)
FR2334820B1 (enExample)
FR2324087B1 (enExample)
JPS5255547U (enExample)
JPS5325611Y2 (enExample)
JPS5426687B2 (enExample)
JPS5648617B2 (enExample)
JPS51132311U (enExample)
JPS51152921U (enExample)
JPS5190517U (enExample)
JPS5220300U (enExample)
JPS523932U (enExample)
JPS51126464U (enExample)
JPS50104670U (enExample)
JPS5189490U (enExample)
JPS5291243U (enExample)
CH591852A5 (enExample)
CH597805A5 (enExample)
CH594362A5 (enExample)
CH592460A5 (enExample)
CH595470A5 (enExample)
CH592273A5 (enExample)
CH592204A5 (enExample)
CH604323A5 (enExample)

Legal Events

Date Code Title Description
ST Notification of lapse